Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Hansa Biopharma
Hansa Biopharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Idefirix
Imlifidase
2020-08-25
Kidney transplantation
,
Immunologic desensitization
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Imlifidase
healthy volunteers/patients
,
duchenne muscular dystrophy
,
kidney diseases
,
graft rejection
,
renal insufficiency
,
guillain-barre syndrome
,
thrombotic thrombocytopenic purpura
,
thrombocytopenic purpura
,
purpura
,
retinal diseases
,
chronic renal insufficiency
,
crigler-najjar syndrome
,
kidney transplantation
,
chronic kidney failure
,
anti-glomerular basement membrane disease
,
psychology rejection
Lornoxicam
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
Bevifimod
candidiasis
,
candidemia
,
invasive candidiasis
,
aspergillosis
Corticorelin
multiple myeloma
,
plasma cell neoplasms
,
bacterial infections
,
hiv infections
,
restless legs syndrome
,
syndrome
,
irritable bowel syndrome
,
renal insufficiency
,
chronic kidney failure
,
anemia
,
kidney diseases
,
chronic renal insufficiency
,
otitis media
,
streptococcal infections
,
otitis
,
chronic obstructive pulmonary disease
,
lung diseases
,
asthma
,
malaria
Globulin, immune
pancreatic neoplasms
,
neoplasm metastasis
,
ovarian neoplasms
,
aplastic anemia
,
healthy volunteers/patients
,
chronic kidney failure
,
pancreatic ductal carcinoma
,
non-small-cell lung carcinoma
,
neoplasms
,
urethral neoplasms
,
pelvic neoplasms
,
breast neoplasms
,
squamous cell carcinoma of head and neck
,
urologic neoplasms
,
transitional cell carcinoma
,
non-hodgkin lymphoma
,
carcinoma
,
adenocarcinoma
,
prostatic neoplasms
,
colorectal neoplasms
,
focal segmental glomerulosclerosis
,
germ cell and embryonal neoplasms
,
psoriatic arthritis
,
kidney diseases
,
stomach neoplasms
,
macular edema
,
recurrence
,
graft vs host disease
,
hepatitis c
,
hepatitis
,
hepatitis a
,
liver diseases
,
virus diseases
,
epstein-barr virus infections
,
hepatocellular carcinoma
,
liver neoplasms
,
endometrial neoplasms
,
arthritis
,
liver transplantation
,
urinary bladder neoplasms
,
ureteral neoplasms
,
inflammation
,
encephalitis
,
organ transplantation
,
kidney transplantation
,
psoriasis
,
rheumatoid arthritis
,
diabetes mellitus
,
bronchiolitis obliterans syndrome
,
atopic dermatitis
,
dermatitis
,
skin diseases
,
pityriasis rubra pilaris
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
lymphoma
,
b-cell lymphoma
,
pregnancy
,
graft rejection
,
glycogen storage disease type ii
Bos taurus adrenal cortex corticosteroids
healthy volunteers/patients
,
breast neoplasms
,
renal cell carcinoma
,
brain neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
kidney neoplasms
,
atopic dermatitis
,
eczema
,
dermatitis
,
immune system diseases
,
inflammation
,
bronchial diseases
,
hypersensitivity
,
immediate hypersensitivity
,
respiratory hypersensitivity
,
colorectal neoplasms
,
gastroesophageal reflux
,
bullous pemphigoid
,
churg-strauss syndrome
,
nasal polyps
,
nasopharyngeal neoplasms
,
eosinophilic esophagitis
,
peptic esophagitis
,
esophagitis
,
asthma
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
,
lung diseases
,
systemic lupus erythematosus
,
pulmonary eosinophilia
,
respiratory tract diseases
,
eosinophilia
,
respiration disorders
,
emphysema
,
respiratory sounds
,
disease progression
,
allergic rhinitis
,
rhinitis
,
allergic rhinitis perennial
,
hypercholesterolemia
,
metabolic bone diseases
,
osteoporosis
,
bone fractures
,
osteoporotic fractures
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use